Suchergebnisse - (Subject:"Siltuximab")

PubPharm (124)

1

A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab

enthalten in: Chemotherapy | 2024

von Plano, F. | Mancuso, S. | Camarda, G. | +6

2

Siltuximab administration results in spurious IL-6 elevation in peripheral blood

enthalten in: American journal of hematology | 2024

von Mango, N. | Pierson, S. | Sarmiento Bustamante, M. | +3

3

Siltuximab as a primary treatment for cytokine release syndrome in a patient receiving a bispecific antibody in a clinical trial setting

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Lipe, B. | Renaud, T.

4

van Rhee F, Rosenthal A, Kanhai K, et al. Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Adv. 2022;6(16):4773-4781

enthalten in: Blood advances | 2023

5

Therapy of Castleman's disease with siltuximab - case report and review of literature

enthalten in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti | 2023

von Adam, Z. | Zeman, D. | Chodacki, A. | +8

6

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2022

von van Rhee, F. | Rosenthal, A. | Kanhai, K. | +4

7

Siltuximab treatment of Castleman's disease could interfere with the diagnostic process of cellulitis

enthalten in: Italian journal of dermatology and venereology | 2022

von Messina, M. | Barruscotti, S. | Ciolfi, C. | +2

8

Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease : A Spectrum of Disease?

enthalten in: The American Journal of dermatopathology | 2022

von Drissi, M. | Dunlap, R. | Clayton, L. | +3

9

COVID-19 acute respiratory distress syndrome : A simulation study of the effects of combination therapy with tocilizumab and siltuximab

enthalten in: British journal of clinical pharmacology | 2022

von Doyle, E. | Bentley, D. | Dodds, M.

10

A New Approach to the Management of COVID-19. Antagonists of IL-6 : Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]